Photo: KENT NISHIMURA / AFP / Getty Images
The Pentagon has paused new guidelines that required testosterone screening for male service members aged 30 and older. The guidelines, announced by War Secretary Pete Hegseth in a social media video titled "The High-T Department of War," were rescinded just a day after their introduction. The War Department is currently updating the guidelines and plans to release a final version soon.
Hegseth initially announced the annual screening program to ensure service members maintain optimal testosterone levels, which he described as essential for maintaining a "warrior ethos" and physical readiness. The program was to be part of the periodic health assessment for troops over 30, while younger personnel could opt in voluntarily. Treatment options, including testosterone replacement therapy, were to be available for those diagnosed with low testosterone levels, a condition known as "low T."
According to the American Legion, testosterone levels naturally decline by 1% to 2% per year after age 30, leading to symptoms like fatigue and muscle loss. Hegseth emphasized that the initiative was not about artificial enhancement but about restoring natural capabilities.
The decision to pause the guidelines comes amid discussions on the necessity and implications of testosterone therapy. Experts, such as Dr. Mohit Khera, have noted that while therapy can improve symptoms of low testosterone, it carries risks, including infertility and cardiovascular issues. The BBC reported that Democratic lawmakers have called for hormone testing to be available for both men and women, highlighting the need for comprehensive health care.
The Pentagon's decision to revise the guidelines reflects ongoing debates about the role of testosterone therapy in military readiness and health care. The updated guidelines are expected to address these concerns and provide a clear framework for implementation.